Ezetimibe Supplier-Buyer Network — Trade Flow Analysis

Name: Ezetimibe Supplier-Buyer Trade Network Dataset — 169+ Indian Exporters, 22+ Importers, 85+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Ezetimibe supplier network, Ezetimibe buyers, pharmaceutical export India, Ezetimibe trade data

TransData Nexus

Ezetimibe

India Pharmaceutical Trade Intelligence

$514.5M169 Suppliers85 CountriesHS 30049099

ExportsIndia → UNITED STATES44.9%India → GERMANY41.4%

ImportsMALTA → India$3.0M GERMANY → India$37.8K

#1 Supplier: PIRAMAL PHARMA

Who Supplies Ezetimibe? Top Manufacturers & Buyers 2026 — PIRAMAL PHARMA LIMITED Leads | TransData Nexus | TransData Nexus

1PIRAMAL PHARMA LIMITED

PIRAMAL PHARMA LIMITED is the first-largest Ezetimibe exporter from India, with a market share of 60.1% and a total export value of $309.1M across 269 shipments. Their average shipment value of $1.1M is above the market average of $102.2K, suggesting premium or bulk contract pricing.

PIRAMAL PHARMA LIMITED serves 5 named buyers in our database. DAIICHI SANKYO EUROPE GMBH is the dominant customer, accounting for 64.4% of this supplier's tracked business. Top customers include:

• DAIICHI SANKYO EUROPE GMBH — $199.1M across 173 shipments (64.4% of this supplier's total exports)

• PCI PHARMA SERVICES — $108.2M across 94 shipments (35.0% of this supplier's total exports)

• DAIICHI SANKYO BRASI — $818.0K across 1 shipments (0.3% of this supplier's total exports)

• DAIICHI SANKYO EUROPE GMBH — $590.3K across 1 shipments (0.2% of this supplier's total exports)

• PCI PHARMA SERVICES — $368.6K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: PIRAMAL PHARMA LIMITED's per-shipment value of $1.1M is 1024% above the market average of $102.2K, consistent with large-order contracts or value-added formulations.

2ALKEM LABORATORIES LIMITED

ALKEM LABORATORIES LIMITED is the second-largest Ezetimibe exporter from India, with a market share of 20.4% and a total export value of $104.9M across 389 shipments. Their average shipment value of $269.7K is above the market average of $102.2K, suggesting premium or bulk contract pricing.

ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. ASCEND LABORATORIES LLC is the dominant customer, accounting for 94.7% of this supplier's tracked business. Top customers include:

• ASCEND LABORATORIES LLC — $99.4M across 368 shipments (94.7% of this supplier's total exports)

• ASCEND LABORATORIES LLC — $4.0M across 15 shipments (3.8% of this supplier's total exports)

• PHARMACOR PTY LTD.,. — $678.3K across 3 shipments (0.6% of this supplier's total exports)

• ASCEND GMBH — $501.0K across 2 shipments (0.5% of this supplier's total exports)

• ASCEND LABORATORIES LLC — $366.3K across 1 shipments (0.3% of this supplier's total exports)

Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $269.7K is 164% above the market average of $102.2K, consistent with large-order contracts or value-added formulations.

3INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the third-largest Ezetimibe exporter from India, with a market share of 2.2% and a total export value of $11.5M across 333 shipments. Their average shipment value of $34.5K is below the market average of $102.2K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. NEXTPHARMA LOGISTIC GMBH is the dominant customer, accounting for 58.2% of this supplier's tracked business. Top customers include:

• NEXTPHARMA LOGISTIC GMBH — $6.7M across 194 shipments (58.2% of this supplier's total exports)

• ACCORD HEALTHCARE PTE LTD — $2.7M across 78 shipments (23.3% of this supplier's total exports)

• TO THE ORDER — $912.9K across 26 shipments (7.9% of this supplier's total exports)

• ACCORD HEALTHCARE SDN BHD — $639.7K across 19 shipments (5.6% of this supplier's total exports)

• STANDARD CHARTERED B — $567.6K across 16 shipments (4.9% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (333 shipments) at a per-shipment value of $34.5K, indicating a broad distribution network with many smaller, regular orders.

4MEDREICH LIMITED

MEDREICH LIMITED is the fourth-largest Ezetimibe exporter from India, with a market share of 1.9% and a total export value of $9.9M across 406 shipments. Their average shipment value of $24.4K is below the market average of $102.2K, reflecting a high-volume, competitive pricing strategy.

MEDREICH LIMITED serves 5 named buyers in our database. BGP PRODUCTS GMBH is the dominant customer, accounting for 76.0% of this supplier's tracked business. Top customers include:

• BGP PRODUCTS GMBH — $7.5M across 309 shipments (76.0% of this supplier's total exports)

• BGP PRODUCTS GMBH — $2.2M across 91 shipments (22.4% of this supplier's total exports)

• ABBOTT LABORATORIES — $69.1K across 3 shipments (0.7% of this supplier's total exports)

• ABBOT LABORATORIES P — $46.1K across 2 shipments (0.5% of this supplier's total exports)

• MEDREICH PLC — $42.4K across 2 shipments (0.4% of this supplier's total exports)

Key Insight: MEDREICH LIMITED operates with high shipment frequency (406 shipments) at a per-shipment value of $24.4K, indicating a broad distribution network with many smaller, regular orders.

5MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the fifth-largest Ezetimibe exporter from India, with a market share of 1.2% and a total export value of $6.0M across 246 shipments. Their average shipment value of $24.3K is below the market average of $102.2K, reflecting a high-volume, competitive pricing strategy.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• VIATRIS BV C/O LIVLINA, — $2.8M across 114 shipments (46.2% of this supplier's total exports)

• CSP MYLAN SAS AT CSP LABO 274 — $1.2M across 50 shipments (20.4% of this supplier's total exports)

• CSP VIATRIS SANT? AT — $826.0K across 34 shipments (13.8% of this supplier's total exports)

• MYLAN IRELAND C/O AL — $608.1K across 25 shipments (10.2% of this supplier's total exports)

• CSP VIATRIS SANTE AT — $566.7K across 23 shipments (9.5% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (246 shipments) at a per-shipment value of $24.3K, indicating a broad distribution network with many smaller, regular orders.

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Ezetimibe exporter from India, with a market share of 1.0% and a total export value of $5.0M across 191 shipments. Their average shipment value of $26.3K is below the market average of $102.2K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 62.4% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $3.1M across 119 shipments (62.4% of this supplier's total exports)

• M/S. RANBAXY PHARMAC — $678.9K across 26 shipments (13.5% of this supplier's total exports)

• M/S. RANBAXY (MALAYS — $507.2K across 19 shipments (10.1% of this supplier's total exports)

• M/S. RANBAXY PHARMAC — $486.3K across 18 shipments (9.7% of this supplier's total exports)

• M/S. RANBAXY (MALAYS — $216.1K across 8 shipments (4.3% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (191 shipments) at a per-shipment value of $26.3K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Ezetimibe imports from India, with a total trade value of $231.1M across 313 shipments — representing a 44.9% share of all Ezetimibe exports. The average shipment value of $738.4K is above the global average of $102.2K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Ezetimibe importers in United States: PCI PHARMA SERVICES is the largest buyer, accounting for 47.2% ($109.0M) of this market's total imports.

• PCI PHARMA SERVICES — $109.0M (47.2% of United States's total)

• ASCEND LABORATORIES LLC — $99.8M (43.2% of United States's total)

• ASCEND LABORATORIES,LLC — $6.7M (2.9% of United States's total)

Key Insight: United States's per-shipment average of $738.4K (622% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Ezetimibe imports from India.

Primary Market

Secondary Market

2Germany

Germany ranks as the second-largest destination for Ezetimibe imports from India, with a total trade value of $213.0M across 272 shipments — representing a 41.4% share of all Ezetimibe exports. The average shipment value of $783.0K is above the global average of $102.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Ezetimibe importers in Germany: DAIICHI SANKYO EUROPE GMBH is the largest buyer, accounting for 94.0% ($200.3M) of this market's total imports.

• DAIICHI SANKYO EUROPE GMBH — $200.3M (94.0% of Germany's total)

• NEXTPHARMA LOGISTIC GMBH — $7.2M (3.4% of Germany's total)

• MICRO LABS GMBH — $2.6M (1.2% of Germany's total)

Key Insight: Germany's per-shipment average of $783.0K (666% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Ezetimibe imports from India.

Primary Market

Secondary Market

3Netherlands

Netherlands ranks as the third-largest destination for Ezetimibe imports from India, with a total trade value of $20.3M across 566 shipments — representing a 4.0% share of all Ezetimibe exports. The average shipment value of $35.9K is below the global average of $102.2K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Ezetimibe importers in Netherlands: BGP PRODUCTS GMBH is the largest buyer, accounting for 80.4% ($16.4M) of this market's total imports.

• BGP PRODUCTS GMBH — $16.4M (80.4% of Netherlands's total)

Key Insight: Netherlands receives frequent, smaller shipments of Ezetimibe — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Netherlands is a key market for Ezetimibe imports from India.

Primary Market

Secondary Market

4Australia

Australia ranks as the fourth-largest destination for Ezetimibe imports from India, with a total trade value of $6.8M across 25 shipments — representing a 1.3% share of all Ezetimibe exports. The average shipment value of $271.9K is above the global average of $102.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ezetimibe importers in Australia: APOTEX PTY LIMITED is the largest buyer, accounting for 19.6% ($1.3M) of this market's total imports.

• APOTEX PTY LIMITED — $1.3M (19.6% of Australia's total)

Key Insight: Australia's per-shipment average of $271.9K (166% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Ezetimibe imports from India.

Primary Market

Secondary Market

5Belgium

Belgium ranks as the fifth-largest destination for Ezetimibe imports from India, with a total trade value of $6.8M across 104 shipments — representing a 1.3% share of all Ezetimibe exports. The average shipment value of $65.3K is below the global average of $102.2K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Ezetimibe importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 49.9% ($3.4M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $3.4M (49.9% of Belgium's total)

• VIATRIS BV C/O LIVLINA, — $2.8M (40.6% of Belgium's total)

Key Insight: Belgium receives frequent, smaller shipments of Ezetimibe — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Belgium is a key market for Ezetimibe imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ezetimibe.
2.Flow Mapping: 169 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,033 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 85 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

5,033 Verified Shipments

169 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Ezetimibe

Ezetimibe

Who Supplies Ezetimibe? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Ezetimibe — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Ezetimibe? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Ezetimibe Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1PIRAMAL PHARMA LIMITED

2ALKEM LABORATORIES LIMITED

3INTAS PHARMACEUTICALS LIMITED

4MEDREICH LIMITED

5MYLAN LABORATORIES LIMITED

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

From Indian Factories to Global Pharmacies — How Ezetimibe Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Ezetimibe Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Germany

3Netherlands

4Australia

5Belgium

People Also Ask — Ezetimibe Supplier & Trade Network

Ezetimibe Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology